Cargando…
Venlafaxine as an Adjuvant Therapy for Inflammatory Bowel Disease Patients With Anxious and Depressive Symptoms: A Randomized Controlled Trial
BACKGROUND AND AIMS: The effect of antidepressant therapy on Inflammatory Bowel Disease (IBD) remains controversial. This trial aimed to assess whether adding venlafaxine to standard therapy for IBD improved the quality of life (QoL), mental health, and disease activity of patients with IBD with anx...
Autores principales: | Liang, Chang, Chen, Pingrun, Tang, Yu, Zhang, Chuheng, Lei, Na, Luo, Ying, Duan, Shihao, Zhang, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160994/ https://www.ncbi.nlm.nih.gov/pubmed/35664492 http://dx.doi.org/10.3389/fpsyt.2022.880058 |
Ejemplares similares
-
Symptoms of anxiety and depression associated with steroid efficacy and clinical outcomes in patients with inflammatory bowel disease
por: Duan, Shihao, et al.
Publicado: (2023) -
Symptoms of anxiety/depression is associated with more aggressive inflammatory bowel disease
por: Gao, Xin, et al.
Publicado: (2021) -
Interval Training Improves Depressive Symptoms But Not Anxious Symptoms in Healthy Women
por: Viana, Ricardo Borges, et al.
Publicado: (2019) -
Development of Obsessive-Compulsive Symptoms Following Abrupt Discontinuation of Venlafaxine
por: Gahr, Maximilian, et al.
Publicado: (2020) -
Resilience, Cardiological Outcome, and Their Correlations With Anxious-Depressive Symptoms and Quality of Life in Patients With an Implantable Cardioverter Defibrillator
por: Isella, Celeste, et al.
Publicado: (2021)